CUPR CUPRINA HOLDINGS (CAYMAN) LIMITED

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET

Individual and institutional investors, advisors, and analysts are invited to attend

SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company’s management team, including Chief Executive Officer, David Quek, will present at the Skyline Signature Series™ on Wednesday, October 8th, 2025, at 11:00 AM ET. 

This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. All investors must pre-register.

Event:Skyline Signature Series™
Date:Wednesday, October 8, 2025
Time:11:00 AM ET
Registration:

ABOUT THE SKYLINE SIGNATURE SERIES™

The Skyline Signature Series provides public companies with a convenient and effective forum to communicate their story to a diverse audience of financial professionals through live virtual presentations. Our financial community participants are carefully curated and qualified by Skyline Corporate Communications Group, LLC (SCCG). Each individual must register and be individually vetted by SCCG to attend so that presenters are ensured of a high-quality, informed, and diverse audience of financial professionals.

SCCG will be compensated by Cuprina Holdings (Cayman) Limited for providing investor relations services relating to the Company’s securities. Please see the 17(b) Disclaimer and Disclosure Statement here:

About Skyline Corporate Communications Group, LLC

Skyline Corporate Communications Group, LLC, with offices in Boston and New York City, is an investor relations and corporate communications firm that provides strategic messaging and investor communications consulting services for public corporations. Skyline delivers strategic assistance for companies in the financial markets and investment community by effectively communicating their corporate message and competitive advantages. Our team has worked with scores of U.S.-listed public companies worldwide across diverse industries and various market caps. We have experience with shareholder activism and crisis communications and also work with late-stage private companies to help prepare them to enter the public marketplace.

For additional information on Skyline CCG, please visit:

About Cuprina Holdings (Cayman) Limited

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https:// . 

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Cuprina Holdings (Cayman) Limited Investor Contact

Investor Relations

c/o Blk 1090 Lower Delta Road #06-08

Singapore 169201



Email:

Investor Relations Inquiries:

Skyline Corporate Communications Group, LLC

Scott Powell, President

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

Office: (646) 893-5835

Email:



EN
06/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CUPRINA HOLDINGS (CAYMAN) LIMITED

 PRESS RELEASE

Cuprina to Present Live, Answer Questions, at Skyline Signature Series...

Cuprina to Present Live, Answer Questions, at Skyline Signature Series™ on October 8th, 2025, at 11:00 AM ET Individual and institutional investors, advisors, and analysts are invited to attend SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company’s management team, includi...

 PRESS RELEASE

Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- ...

Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology SINGAPORE, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced it has secured exclusive licensing rights to Southeast Asia’s first medical waste recycling technology developed under t...

 PRESS RELEASE

Cuprina Reaffirms Commitment to Shareholders and Patients Following R...

Cuprina Reaffirms Commitment to Shareholders and Patients Following Recent Stock Market Activity Singapore, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”) issued the following statement in response to recent unusual trading activity and speculation surrounding the Company. Over the past week, the Company’s stock has experienced heightened trading volatility, which we understand has raised concerns among some shareholders. We want to take this opportunity to reaffirm that Cuprina is a fully operational, legally compliant, a...

 PRESS RELEASE

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Ther...

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that Dr. Ronald A. Sherman, a leading innovator in the use of medical ...

 PRESS RELEASE

Cuprina Provides Update on Research Studies with Three Leading Educati...

Cuprina Provides Update on Research Studies with Three Leading Education Institutes SINGAPORE, June 30, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today provided an update on progress achieved in relation to three studies carried out with institutes of higher learning. The studies, each one year in length, were aimed...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch